Mead Johnson Nutrition CO (MJN) : Bls Capital Fondsmaeglerselskab As reduced its stake in Mead Johnson Nutrition CO by 43.11% during the most recent quarter end. The investment management company now holds a total of 130,210 shares of Mead Johnson Nutrition CO which is valued at $11,880,360 after selling 98,665 shares in Mead Johnson Nutrition CO , the firm said in a disclosure report filed with the SEC on Jul 19, 2016.Mead Johnson Nutrition CO makes up approximately 5.12% of Bls Capital Fondsmaeglerselskab As’s portfolio.
Other Hedge Funds, Including , Simplex Trading sold out all of its stake in MJN during the most recent quarter. The investment firm sold 72,469 shares of MJN which is valued $6,612,072. Arcadia Investment Management Corpmi added MJN to its portfolio by purchasing 13 company shares during the most recent quarter which is valued at $1,186. Douglass Winthrop Advisors sold out all of its stake in MJN during the most recent quarter. The investment firm sold 8,695 shares of MJN which is valued $790,810.
Mead Johnson Nutrition CO opened for trading at $91.24 and hit $91.4 on the upside on Wednesday, eventually ending the session at $91.24, with a gain of 0.12% or 0.11 points. The heightened volatility saw the trading volume jump to 4,56,735 shares. Company has a market cap of $17,031 M.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by BofA/Merrill to ” Neutral” on Jul 13, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.